LSB
LakeShore Biopharma
7 hedge funds and large institutions have $330K invested in LakeShore Biopharma in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.58K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$4.46K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$87.3K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$43K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$686 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $119K | – | – | – |
|
|
HA
2
HHLR Advisors
Grand Cayman,
Cayman Islands
| $76.7K | – | – | – |
|
|
O
3
OrbiMed
New York
| $55.9K | -$87.3K | -85,629 | -61% |
|
|
SCM
4
Superstring Capital Management
New York
| $31.4K | – | – | – |
|
5
Barclays
London,
United Kingdom
| $25K | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $15.3K | +$4.46K | +4,377 | +41% |
|
|
7
UBS Group
Zurich,
Switzerland
| $6.6K | +$5.58K | +5,469 | +547% |
|
|
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$43K | -1,048,320 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$686 | -280 | Closed |
|